Literature DB >> 21538026

Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification.

Barbara Klink1, Ben Schlingelhof, Martin Klink, Karen Stout-Weider, Stephan Patt, Evelin Schrock.   

Abstract

BACKGROUND: Glioblastomas are the most common and most malignant brain tumors in adults. A small subgroup of glioblastomas contains areas with histological features of oligodendroglial differentiation (GBMO). Our objective was to genetically characterize the oligodendroglial and the astrocytic parts of GBMOs and correlate morphologic and genetic features with clinical data.
METHODS: The oligodendroglial and the "classic" glioblastoma parts of 13 GBMO were analyzed separately by interphase fluoreszence in situ hybridization (FISH) on paraffin sections using a custom probe set (regions 1p, 1q, 7q, 10q, 17p, 19q, cen18, 21q) and by comparative genomic hybridization (CGH) of microdissected paraffin embedded tumor tissue.
RESULTS: We identified four distinct genetic subtypes in 13 GBMOs: an "astrocytic" subtype (9/13) characterized by +7/-10; an "oligodendroglial" subtype with -1p/-19q (1/13); an "intermediate" subtype showing +7/-1p (1/13), and an "other" subtype having none of the former aberrations typical for gliomas (2/13). The different histological tumor parts of GBMO revealed common genetic changes in all tumors and showed additional aberrations specific for each part.
CONCLUSION: Our findings demonstrate the monoclonal origin of GBMO followed by the development of the astrocytic and oligodendroglial components. The diagnostic determination of the genetic signatures may allow for a better prognostication of the patients.

Entities:  

Mesh:

Year:  2011        PMID: 21538026     DOI: 10.1007/s13402-011-0034-8

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  56 in total

1.  Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2.

Authors:  Peter H Wessels; Albert Twijnstra; Alfons G H Kessels; Bela Krijne-Kubat; Paul H Theunissen; Monique I J Ummelen; Frans C S Ramaekers; Anton H Hopman
Journal:  Genes Chromosomes Cancer       Date:  2002-03       Impact factor: 5.006

2.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

Authors:  J S Smith; A Perry; T J Borell; H K Lee; J O'Fallon; S M Hosek; D Kimmel; A Yates; P C Burger; B W Scheithauer; R B Jenkins
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

3.  Glioblastomas with an oligodendroglial component: a pathological and molecular study.

Authors:  J He; K Mokhtari; M Sanson; Y Marie; M Kujas; S Huguet; P Leuraud; L Capelle; J Y Delattre; J Poirier; K Hoang-Xuan
Journal:  J Neuropathol Exp Neurol       Date:  2001-09       Impact factor: 3.685

4.  Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.

Authors:  S H Bigner; M R Matthews; B K Rasheed; R N Wiltshire; H S Friedman; A H Friedman; T T Stenzel; D M Dawes; R E McLendon; D D Bigner
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

5.  Impact of genotype and morphology on the prognosis of glioblastoma.

Authors:  Matthias C Schmidt; Sven Antweiler; Nina Urban; Wolf Mueller; A Kuklik; Birgit Meyer-Puttlitz; Otmar D Wiestler; David N Louis; Rolf Fimmers; Andreas von Deimling
Journal:  J Neuropathol Exp Neurol       Date:  2002-04       Impact factor: 3.685

6.  Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis.

Authors:  Luciana Wernersbach Pinto; Maria Betania Mahler Araújo; Andre L Vettore; Liana Wernersbach; André Campana C Leite; Leila Maria C Chimelli; Fernando Augusto Soares
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.064

Review 7.  Genetic pathways to primary and secondary glioblastoma.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

8.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

9.  Clonality of oligoastrocytomas.

Authors:  Zhi-Qian Dong; Jesse Chung-Sean Pang; Carol Yuen-Kwan Tong; Liang-Fu Zhou; Ho-Keung Ng
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

10.  Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas.

Authors:  Kavita S Reddy
Journal:  Cancer Genet Cytogenet       Date:  2008-07-15
View more
  8 in total

1.  Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age.

Authors:  Sang Yun Ha; So Young Kang; In-Gu Do; Yeon-Lim Suh
Journal:  J Neurooncol       Date:  2013-02-15       Impact factor: 4.130

Review 2.  Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.

Authors:  Alexandra McAleenan; Hayley E Jones; Ashleigh Kernohan; Tomos Robinson; Lena Schmidt; Sarah Dawson; Claire Kelly; Emmelyn Spencer Leal; Claire L Faulkner; Abigail Palmer; Christopher Wragg; Sarah Jefferies; Sebastian Brandner; Luke Vale; Julian Pt Higgins; Kathreena M Kurian
Journal:  Cochrane Database Syst Rev       Date:  2022-03-02

3.  A misplaced lncRNA causes brachydactyly in humans.

Authors:  Philipp G Maass; Andreas Rump; Herbert Schulz; Sigmar Stricker; Lisanne Schulze; Konrad Platzer; Atakan Aydin; Sigrid Tinschert; Mary B Goldring; Friedrich C Luft; Sylvia Bähring
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

Review 4.  The biology and mathematical modelling of glioma invasion: a review.

Authors:  J C L Alfonso; K Talkenberger; M Seifert; B Klink; A Hawkins-Daarud; K R Swanson; H Hatzikirou; A Deutsch
Journal:  J R Soc Interface       Date:  2017-11       Impact factor: 4.118

5.  Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil.

Authors:  Dayane B Koshiyama; Patrícia Trevisan; Carla Graziadio; Rafael F M Rosa; Bibiana Cunegatto; Juliete Scholl; Valentina O Provenzi; Alexandre P de Sá; Fabiano P Soares; Maíra C Velho; Nelson de A P Filho; Ceres A Oliveira; Paulo R G Zen
Journal:  J Neurooncol       Date:  2017-08-30       Impact factor: 4.130

6.  Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status.

Authors:  Jae Kyung Myung; Hwa Jin Cho; Hanna Kim; Chul-Kee Park; Se Hoon Lee; Seung Hong Choi; Peom Park; Jung Min Yoon; Sung-Hye Park
Journal:  Transl Oncol       Date:  2014-12       Impact factor: 4.243

7.  The Study of "Dihydropyrimidinase Related Proteins (DRPs)" Expression Changes Influence in Malignant Astrocytoma Brain Tumor.

Authors:  Mehdi Pooladi; Mostafa Rezaei-Tavirani; Mehrdad Hashemi; Saeed Hesami-Tackallou; Solmaz Khaghani-Razi-Abad; Afshin Moradi; Ali Reza Zali; Masoumea Mousavi; Azadeh Rakhshan; Leila Firozi-Dalvand; Roghaye Omidi
Journal:  Iran J Cancer Prev       Date:  2014

8.  Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.

Authors:  Benjamin H Hinrichs; Scott Newman; Christina L Appin; William Dunn; Lee Cooper; Rini Pauly; Jeanne Kowalski; Michael R Rossi; Daniel J Brat
Journal:  Acta Neuropathol Commun       Date:  2016-01-13       Impact factor: 7.801

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.